SCHEMBL5292525

SCHEMBL5292525

CC(c1ccccc1)C(P)(c1ccccc1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 4/20 0.37
RIPK1 Q13546 1/20 0.36
CYP2D6 P10635 2/20 0.35
ADRA2A P08913 1/20 0.35
ADRA2C P18825 1/20 0.35
LMNA P02545 1/20 0.35
HIF1A Q16665 1/20 0.35
KDM4E B2RXH2 1/20 0.35
CYP1A2 P05177 1/20 0.35
KCNN4 O15554 2/20 0.34
MAPK1 P28482 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CACNA1F O60840 1/20 0.34
CHRM2 P08172 1/20 0.34
CHRM1 P11229 1/20 0.34
ADRA2B P18089 1/20 0.34
CHRM3 P20309 1/20 0.34
ADRA1A P35348 1/20 0.34
HRH1 P35367 1/20 0.34
OPRK1 P41145 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL812642 0.98 TAAR1 (0.35) TAAR1RIPK1CYP2D6ADRA2AADRA2C
Iodide SCHEMBL5085038 0.98 TAAR1 (0.35) TAAR1RIPK1CYP2D6ADRA2AADRA2C
Hydrochloric Acid SCHEMBL5092624 0.98 ALDH1A1 (0.38) TAAR1RIPK1CYP2D6ADRA2AADRA2C
SCHEMBL7206394 0.82 CYP2D6 (0.40) TAAR1RIPK1CYP2D6ADRA2AADRA2C
SCHEMBL18729670 0.80 TAAR1 (0.35) TAAR1RIPK1CYP2D6ADRA2AADRA2C
SCHEMBL6741619 0.78 TAAR1 (0.41) TAAR1RIPK1CYP2D6ADRA2AADRA2C
SCHEMBL27533645 0.78 CYP2D6 (0.43) TAAR1RIPK1CYP2D6HIF1ACYP1A2
SCHEMBL15658444 0.78
Bromide SCHEMBL7400155 0.77 CYP2D6 (0.36) TAAR1RIPK1CYP2D6ADRA2AADRA2C
SCHEMBL15656382 0.77 TAAR1 (0.33) TAAR1RIPK1CYP2D6ADRA2AADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12269969-B2 Polishing composition and method with high selectivity for silicon nitride and polysilicon over silicon oxide CMC MATERIALS LLC (US) 2025-04-08 US claimed
EP-4048751-B1 POLISHING COMPOSITION AND METHOD WITH HIGH SELECTIVITY FOR SILICON NITRIDE AND POLYSILICON OVER SILICON OXIDE CMC MAT LLC (US) 2025-03-19 EP claimed
EP-4048751-A1 POLISHING COMPOSITION AND METHOD WITH HIGH SELECTIVITY FOR SILICON NITRIDE AND POLYSILICON OVER SILICON OXIDE CMC Materials, Inc. (US) 2022-08-31 EP claimed
CN-107710462-B Electrochemical hydrogen storage electrode and battery 巴斯夫公司 2022-08-02 CN claimed
WO-2021081145-A1 POLISHING COMPOSITION AND METHOD WITH HIGH SELECTIVITY FOR SILICON NITRIDE AND POLYSILICON OVER SILICON OXIDE CMC MATERIALS, INC. (US) 2021-04-29 WO claimed
US-20210115297-A1 POLISHING COMPOSITION AND METHOD WITH HIGH SELECTIVITY FOR SILICON NITRIDE AND POLYSILICON OVER SILICON OXIDE CMC MATERIALS LLC 2021-04-22 US claimed
EP-3292578-B1 ELECTROCHEMICAL HYDROGEN STORAGE ELECTRODES AND CELLS BASF CORP (US) 2021-02-24 EP claimed
EP-3218955-A1 ELECTROLYTES AND METAL HYDRIDE BATTERIES BASF Corporation (US) 2017-09-20 EP claimed
US-20160329560-A1 Electrochemical Hydrogen Storage Electrodes and Cells BASF CORPORATION (US) 2016-11-10 US claimed
US-20160141725-A1 Electrolytes and Metal Hydride Batteries BASF CORPORATION 2016-05-19 US claimed
US-20160141727-A1 Electrolytes and Metal Hydride Batteries BASF CORPORATION 2016-05-19 US claimed
EP-0764676-B1 Method of preparing polycarbonate-polysiloxane block copolymers GEN ELECTRIC (US) 2004-04-28 EP claimed
EP-0010843-B1 METHOD OF MAKING 5,6-DIHYDRO-2-METHYL-N-PHENYL-1,4-OXATHIIN-3-CARBOXAMIDE UNIROYAL LTD. (CA) 1983-11-09 EP claimed
US-4225497-A ACID CATALYSTS FOR IMIDATION RHONE-POULENC INDUSTRIES (FR) 1980-09-30 US claimed
US-20260118757-A1 RADIATION-SENSITIVE RESIST COMPOSITION AND PATTERN FORMATION METHOD USING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2026-04-30 US disclosed
EP-3275039-B1 ELECTROLYTES AND METAL HYDRIDE BATTERIES BASF CORP (US) 2025-08-27 EP disclosed
US-20250223244-A1 DEHYDROGENATION METHODS THE TRUSTEES OF BOSTON COLLEGE 2025-07-10 US disclosed
WO-2006131234-A1 COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-12-14 WO disclosed
EP-0686063-B1 A METHOD FOR SEPARATING CATALYST FROM A HYDROFORMYLATION REACTION PRODUCT USING ALKYLATED LIGANDS EXXON CHEMICAL PATENTS INC (US) 1998-08-19 EP disclosed
US-4225497-A ACID CATALYSTS FOR IMIDATION RHONE-POULENC INDUSTRIES (FR) 1980-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260118757-A1 RADIATION-SENSITIVE RESIST COMPOSITION AND PATTERN FORMATION METHOD USING THE SAME SLC39A14, HCN4, SLC11A2 TAAR1 3588/4885RIPK1 2540/4885CYP2D6 4423/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.